Capillary blood collection devices are defined as devices that are used for capillary blood withdrawal. Capillary blood can be obtained by puncturing the finger, earlobe, or heel. It can also be performed by giving an incision on the skin. Its procedure gained wide attention as it withdraws an accurate amount of blood and reduces the chances of anemia. There are various kinds of needles, lancets, and syringes offered by market players for capillary blood collection. The need for blood tests is also increasing as the prevalence of chronic disease increases. Moreover, the rising geriatric population and neonates have put a challenge for invasive blood collecting procedures, which is the reason that minimal invasive capillary blood collection procedure has gained wide attention. Nowadays, the volumetric microsampling technique has gained attention for capillary blood collection. Moreover, new technological advancements are taking place to fulfill the needs of physicians and consumers.
Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-blood-collection-and-sampling-devices-market
Data Bridge Market Research analyzes that the Asia-Pacific Blood Collection and Sampling Devices Market is expected to reach USD 1,505,992.14 thousand by 2030 from USD 887,648.16 thousand in 2022, growing at a CAGR of 7.1% during the forecast period of 2023 to 2030. The venous blood collection and sampling devices segment is expected to dominate the market growth as they are widely used in the diagnosis of chronic disorders in various countries and more due to the availability of more advanced technologies.
Key Findings of the Study
Increased Prevalence of Chronic Diseases
The increased prevalence of chronic diseases is a significant global health concern. Chronic diseases are long-term conditions that progress slowly and require ongoing medical attention and management. These diseases can significantly impact the quality of life of individuals and place a substantial burden on healthcare systems. Blood collection is a common method to obtain small blood samples for various diagnostic tests, such as blood glucose monitoring for diabetes management. Lower middle-income countries are the worst affected by chronic diseases so, the disease also becomes a financial burden for the underprivileged countries. The disease must be diagnosed accurately for the early detection and timely treatment of the disease. For this, efficient blood collection and sampling are necessary, creating a demand for technologically advanced capillary blood testing devices. Thus, the increased prevalence of infectious and chronic diseases is expected to drive the market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 – 2020)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Product (Venous Blood Sampling and Collection Devices, Capillary Blood Collection and Sampling Devices)
|
|
Countries Covered
|
Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific
|
|
Market Players Covered
|
BD (U.S.), TERUMO BCT, INC. (Japan), Thermo Fisher Scientific Inc. (U.S.), Cardinal Health (U.S.), Abbott (U.S.), Cardinal Health (U.S.), Nipro Corporation (Japan), B. Braun Medical Ltd (Germany), ICU Medical, Inc. (U.S.), SARSTEDT AG & Co. KG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Greiner Bio-One International GmbH (Austria), Hindustan Syringes & Medical Devices Ltd (India), Owen Mumford Ltd (U.K.), Sparsh Mediplus (India), Narang Medical Limited (India), and CML Biotech (India)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The Asia-Pacific blood collection and sampling devices market is segmented based on product.
- Based on product, the market is segmented into venous blood collection and sampling devices, capillary blood collection and sampling devices.
In 2023, the venous blood collection and sampling device segment of the product segment is expected to dominate the Asia-Pacific blood collection and sampling devices market
In 2023, the venous blood collection and sampling devices segment is expected to dominate the market with a market share of 61.36% due to the rising cases of chronic disorders.
Major Players
Data Bridge Market Research analyzes Cardinal Health (U.S.), BD (U.S.), Abbott (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Terumo Corporation (Japan) as the major market players in market.
Market Development
- In June 2023, Cardinal Health announced its collaboration with Signify Health to offer in-home clinical and medication management services through its Outcomes business. The company believes that this collaboration will help reduce costs and eliminate gaps in care. This has aided the business in becoming known on a huge scale.
- In March 2023, Abbott received FDA clearance for the first commercially available lab-based blood test to help evaluate concussion. The company believes that this will provide clinicians with an objective way to quickly assess individuals with mild TBIs, also known as concussions. Significant synergy effects between the two organizations improve their offerings to customers and suppliers.
- In March 2022, ICU Medical, Inc participated in the Raymond James 43rd Annual Institutional Investors Conference. The company believes that this will help in business expansion and strategy development. This has aided the business in offering better solutions and product portfolio.
- In January 2020, Nipro Europe Group Companies completed the acquisition of share of a medical device company in Bangladesh. This acquisition helped the company to improve its financial conditions. This has aided the business in engaging in research activities and producing new antibodies that work better.
- In November 2019, Thermo Fisher Scientific Inc. launched easy-to-use Capillary Electrophoresis (CE) platform which utilizes capillary blood samples to obtain forensic results. This launch helped the company to enhance its platform for capillary blood collection devices. This launch has helped the company in expanding oncology diagnostics by accelerating research, solving complex analytical challenges, and improving patient therapies.
Regional Analysis
Geographically, the countries covered in the Asia-Pacific blood collection and sampling devices market report are Japan, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific.
As per Data Bridge Market Research analysis:
Japan is expected to dominate the market and is the fastest-growing country in the Asia-Pacific blood collection and sampling devices market
Japan is expected to dominate and fastest growing country in the market owing to the higher level of investments by market players and manufacturers and the increasing prevalence of oncological diseases and chronic disorders in the country.
For more detailed information about the Asia-Pacific blood collection and sampling devices market report, click here – https://www.databridgemarketresearch.com/reports/asia-pacific-blood-collection-and-sampling-devices-market
